Keros Therapeutics Inc (KROS)

Operating Cash Flow Growth

31.06%

Quarterly · Period ending:

KROS logo

KROS Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported31.06%
KROS Quarterly Cash from Operations YoY % (-223.12% → 31.06%)
High-resolution chart · PNG

KROS operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
31.0637%
-102.1896%
40.6799%
110.6525%
25.5722%
461.6943%
-80.7141%
10.2466%
-29.0899%
-30.1592%
-18.7287%
-38.127%
-36.4852%
-2,299.089%
-9.5988%
-70.3622%
-28.083%
86.416%
-144.8379%
-33.0232%
-77.667%
-29.3719%
-45.3438%
-267.3773%
-97.2774%
-223.1198%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.